Status:
COMPLETED
Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen
Lead Sponsor:
UCB Pharma
Conditions:
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To compare the clinical efficacy of levocetirizine 5 mg and montelukast 10 mg, administered once daily during two consecutive days, on symptoms of seasonal allergic rhinitis occurring in subjects expo...
Eligibility Criteria
Inclusion
- Have had seasonal allergic rhinitis due to Ragweed for the last 2 consecutive years
- Subjects who obtain a minimum sum score, considering SAR related symptoms (mean value), as defined by the protocol
Exclusion
- Any clinically significant condition that might interfere with the treatment evaluation, both for efficacy and safety
- Have used forbidden concomitant medications as defined by the protocol
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
403 Patients enrolled
Trial Details
Trial ID
NCT00315523
Start Date
July 1 2006
End Date
October 1 2006
Last Update
December 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mississauga, Ontario, Canada